Latest MedImmune Stories
QUEBEC CITY, QC, March 30 /PRNewswire-FirstCall/ - Â Medicago Inc.
WASHINGTON, March 29, 2011 /PRNewswire/ -- MedImmune announced today it will present a total of 11 abstracts at the 45th National Immunization Conference (NIC) at the Washington Hilton in Washington, DC, March 28 - 31, 2011.
-The Company launches the clinical development of its seasonal flu vaccine- QUEBEC CITY, March 21 /PRNewswire-FirstCall/ - Medicago Inc.
ROCKVILLE, Md., March 3, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that Maryland State Governor Martin O'Malley will visit the company's headquarters in Rockville, Maryland, on Monday, March 7, to celebrate the recently announced contract valued at up to $179 million.
ROCKVILLE, Md., March 1, 2011 /PRNewswire/ -- Novavax, Inc.
VIENNA, March 1, 2011 /PRNewswire/ -- Today Intercell AG (VSE: ICLL) announced its financial results for Q4 and the preliminary results for the full financial year 2010 and presented an update on the Company's development programs. Increase in IXIAROÂ®/JESPECTÂ® sales by approximately 66% to EUR 12.8m for the full year 2010, due to increased sales in key travel markets and to U.S.
INCLINE VILLAGE, Nev., Feb. 28, 2011 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today reported financial results for the fourth quarter and full year ended December 31, 2010. Total revenues in 2010 were $345.0 million, compared to $318.2 million in 2009.
GAITHERSBERG, Md. and INCLINE VILLAGE, Nev., Feb. 16, 2011 /PRNewswire/ -- PDL BioPharma, Inc.
ROCKVILLE, Md., Feb. 9, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr.
-The Company launches the clinical development of its seasonal flu vaccine- QUEBEC CITY, Feb. 8 /PRNewswire-FirstCall/ - Medicago Inc.
- Sleep; the state or condition of being asleep.